Details for New Drug Application (NDA): 021435
✉ Email this page to a colleague
The generic ingredient in AMVAZ is amlodipine maleate. There are fifty drug master file entries for this compound. Additional details are available on the amlodipine maleate profile page.
Summary for 021435
Tradename: | AMVAZ |
Applicant: | Dr Reddys Labs Inc |
Ingredient: | amlodipine maleate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Oct 31, 2003 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Oct 31, 2003 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Oct 31, 2003 | TE: | RLD: | No |
Complete Access Available with Subscription